FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2957260147> ?p ?o ?g. }

• W2957260147 abstract "Myasthenia gravis is the most common disease affecting the neuromuscular junction. The most common etiology among patients with juvenile myasthenia gravis is the production of antibodies against the acetylcholine receptor. However, the clinical outcome in relation to serum levels of anti-acetylcholine receptor antibodies in juvenile myasthenia gravis has rarely been discussed. We aimed to analyze the correlation between the presence of anti-acetylcholine receptor antibodies and outcome in juvenile myasthenia gravis. Patients diagnosed with juvenile myasthenia gravis younger than of 20 years of age were retrospectively recruited from January 1995 to February 2017 in a tertiary referral medical center. According to the Myasthenia Gravis Foundation of America outcome scale, the primary outcome was complete symptom remission and cessation of medications for at least 1 year measured 2 years after diagnosis. Secondary outcome was complete symptom remission at the last outpatient clinic. A total of 54 patients were followed up for over 2 years. Nine patients (9/54, 16.7%) achieved complete remission without medication use at 2 years after diagnosis. Thirteen (24.1%) patients achieved complete remission during longer follow-up periods. Those with negative anti-acetylcholine receptor antibodies were more likely to achieve complete remission at 2 years (6/15 [40%] vs. 3/39 [7.7%], 95% Confidence interval [CI] 1.670 to 38.323) and at the last outpatient clinic follow-up (8/15 [53.3%] vs. 5/39 [12.8%], 95% CI 2.367 to 20.704). Thirteen patients with comorbid autoimmune thyroid diseases were older than those without disease (11.8 ± 5.8 years old vs. 8.0 ± 6.3 years old, 95% CI 0.018 to 7.33). Moreover, patients negative for anti-acetylcholine receptor antibodies were less likely comorbid with autoimmune thyroid disease (1/35 [2.9%] vs. 12/71 [16.9%], 95% CI 0.018 to 1.161). Juvenile myasthenia gravis patients without anti-acetylcholine antibodies exhibited significantly increased complete remission rates and a reduced likelihood of comorbid autoimmune thyroid diseases compared with those with anti-acetylcholine receptor antibodies among Chinese." @default.
• W2957260147 created "2019-07-23" @default.
• W2957260147 creator A5006635938 @default.
• W2957260147 creator A5011701095 @default.
• W2957260147 creator A5023311970 @default.
• W2957260147 creator A5039558419 @default.
• W2957260147 creator A5040200976 @default.
• W2957260147 creator A5050753551 @default.
• W2957260147 creator A5058324396 @default.
• W2957260147 creator A5061396043 @default.
• W2957260147 creator A5067882948 @default.
• W2957260147 creator A5075048605 @default.
• W2957260147 creator A5076174609 @default.
• W2957260147 creator A5082246930 @default.
• W2957260147 creator A5086810223 @default.
• W2957260147 date "2019-07-18" @default.
• W2957260147 modified "2023-10-15" @default.
• W2957260147 title "Correlation of anti-acetylcholine receptor antibody levels and long-term outcomes of juvenile myasthenia gravis in Taiwan: a case control study" @default.
• W2957260147 cites W1602245959 @default.
• W2957260147 cites W1970107021 @default.
• W2957260147 cites W1977880433 @default.
• W2957260147 cites W1979456658 @default.
• W2957260147 cites W1989939871 @default.
• W2957260147 cites W2010296807 @default.
• W2957260147 cites W2015398414 @default.
• W2957260147 cites W2030485267 @default.
• W2957260147 cites W2040514355 @default.
• W2957260147 cites W2085694036 @default.
• W2957260147 cites W2093384540 @default.
• W2957260147 cites W2097755076 @default.
• W2957260147 cites W2115439533 @default.
• W2957260147 cites W2145615564 @default.
• W2957260147 cites W2158039528 @default.
• W2957260147 cites W2472225729 @default.
• W2957260147 cites W2475786228 @default.
• W2957260147 cites W2659815784 @default.
• W2957260147 cites W2793756090 @default.
• W2957260147 doi "https://doi.org/10.1186/s12883-019-1397-0" @default.
• W2957260147 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6637626" @default.
• W2957260147 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31319795" @default.
• W2957260147 hasPublicationYear "2019" @default.
• W2957260147 type Work @default.
• W2957260147 sameAs 2957260147 @default.
• W2957260147 citedByCount "10" @default.
• W2957260147 countsByYear W29572601472019 @default.
• W2957260147 countsByYear W29572601472020 @default.
• W2957260147 countsByYear W29572601472022 @default.
• W2957260147 countsByYear W29572601472023 @default.
• W2957260147 crossrefType "journal-article" @default.
• W2957260147 hasAuthorship W2957260147A5006635938 @default.
• W2957260147 hasAuthorship W2957260147A5011701095 @default.
• W2957260147 hasAuthorship W2957260147A5023311970 @default.
• W2957260147 hasAuthorship W2957260147A5039558419 @default.
• W2957260147 hasAuthorship W2957260147A5040200976 @default.
• W2957260147 hasAuthorship W2957260147A5050753551 @default.
• W2957260147 hasAuthorship W2957260147A5058324396 @default.
• W2957260147 hasAuthorship W2957260147A5061396043 @default.
• W2957260147 hasAuthorship W2957260147A5067882948 @default.
• W2957260147 hasAuthorship W2957260147A5075048605 @default.
• W2957260147 hasAuthorship W2957260147A5076174609 @default.
• W2957260147 hasAuthorship W2957260147A5082246930 @default.
• W2957260147 hasAuthorship W2957260147A5086810223 @default.
• W2957260147 hasBestOaLocation W29572601471 @default.
• W2957260147 hasConcept C126322002 @default.
• W2957260147 hasConcept C187212893 @default.
• W2957260147 hasConcept C2777960172 @default.
• W2957260147 hasConcept C2778105408 @default.
• W2957260147 hasConcept C2779615886 @default.
• W2957260147 hasConcept C3020110884 @default.
• W2957260147 hasConcept C71924100 @default.
• W2957260147 hasConceptScore W2957260147C126322002 @default.
• W2957260147 hasConceptScore W2957260147C187212893 @default.
• W2957260147 hasConceptScore W2957260147C2777960172 @default.
• W2957260147 hasConceptScore W2957260147C2778105408 @default.
• W2957260147 hasConceptScore W2957260147C2779615886 @default.
• W2957260147 hasConceptScore W2957260147C3020110884 @default.
• W2957260147 hasConceptScore W2957260147C71924100 @default.
• W2957260147 hasIssue "1" @default.
• W2957260147 hasLocation W29572601471 @default.
• W2957260147 hasLocation W29572601472 @default.
• W2957260147 hasLocation W29572601473 @default.
• W2957260147 hasLocation W29572601474 @default.
• W2957260147 hasLocation W29572601475 @default.
• W2957260147 hasLocation W29572601476 @default.
• W2957260147 hasOpenAccess W2957260147 @default.
• W2957260147 hasPrimaryLocation W29572601471 @default.
• W2957260147 hasRelatedWork W124102952 @default.
• W2957260147 hasRelatedWork W1991472959 @default.
• W2957260147 hasRelatedWork W2023878761 @default.
• W2957260147 hasRelatedWork W2351215529 @default.
• W2957260147 hasRelatedWork W2492545249 @default.
• W2957260147 hasRelatedWork W2735026826 @default.
• W2957260147 hasRelatedWork W2971622769 @default.
• W2957260147 hasRelatedWork W2980301535 @default.
• W2957260147 hasRelatedWork W3091215059 @default.
• W2957260147 hasRelatedWork W4256574681 @default.
• W2957260147 hasVolume "19" @default.
• W2957260147 isParatext "false" @default.
• W2957260147 isRetracted "false" @default.
• W2957260147 magId "2957260147" @default.

• next